2024 saw the rise of many generative AI applications in various industries, including healthcare, driving work and operational efficiencies like never before.
It is also one of the technology solutions that came out of an accelerator programme by the National University of Singapore Yong Loo Lin School of Medicine and 22Health Ventures. Interestingly, the clinical AI copilot might have been...
Five digital health startups recently graduated from the accelerator programme of the National University of Singapore Yong Loo Lin School of Medicine and 22Health Ventures. Started as a hackathon event, the NUS Medicine Digital Advanced Technology Accelerator (DATA) supports startups to quickly scale their solutions for improving patient outcomes and clinician productivity.
"It's truly exciting...
The Ministry of Food and Drug Safety in South Korea has approved the first depression diagnosis support AI software-as-a-medical device in the country.
Developed by local AI company Acryl, the product called ACRYL-D01 uses AI to analyse patient interviews to calculate their probability of having depression. It has also been designated as an innovative medical device.
Founded in 2011, Acryl...
When asked by MobiHealthNews how they see AI's place in the sector changing in 2025, executives explained how the focus of AI will shift from what it can do to what it does, and the role the technology can play in extending current provider capacity via clinical decision support, ambient charting, inbox management and streamlining care operations.
Some leaders said AI will revolutionize how...
San Francisco-based data intelligence and AI provider Databricks has raised $10 billion of expected non-dilutive financing in a Series J funding round, completing $8.6 billion to date. The new funding brings the company's valuation to $62 billion.
Thrive Capital, Andreessen Horowitz, GIC, WCM Investment Management, Insight Partners and DST Global coled the round, with participation from existing...
Executives highlighted AI's transformative potential in healthcare when asked by MobiHealthNews how they see AI's place in the sector changing in 2025.
Some expect multimodal AI and advanced diagnostic imaging to make significant strides next year, while others showcased AI's promise in improving diagnostics, addressing provider burnout, automating tasks, streamlining drug development and...
An AI startup supported by conglomerate SK Group has introduced what could be the first pharmacy-specific platform powered by generative AI in South Korea.
Intended for use by professionals in the pharmaceutical industry, including researchers and pharmacists, the search platform called Cheiron is the flagship AI solution by PhynX Lab, a Silicon Valley-based venture under SK Networks.
HOW IT...
Researchers concluded that the strong performance of GPT-4 large language models (LLMs) suggests their potential as a tool to help fill gaps in physicians' knowledge and aid in diagnosing medical conditions in the future, according to a study published in the Journal of Medical Artificial Intelligence.
Physical examinations are important diagnostic tools that can disclose critical insights into a...
MobiHealthNews reached out to executives from across the digital health landscape and questioned them about unexpected and impactful occurrences from the past year.
Leaders singled out the closing of retail clinics, challenges in the Medicare Advantage market, the FDA's concerns about off-label advertising, the wide variety of AI use cases and the plethora of uses for GLP-1s beyond weight...
As 2024 comes to a close, MobiHealthNews asked executives from across the digital health sector about their biggest surprises and most noteworthy events from the year.
The execs highlight AI's potential, oncology imaging breakthroughs, nutrition's role in healthcare, inflated AI valuations, cyberattacks and policy shifts, emphasizing the need for practical integration, patient trust and system...